BD to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

BD (Becton, Dickinson and Company) will present at the 39th Annual J.P. Morgan Healthcare Conference via webcast on January 12, 2021, at 7:30 a.m. Eastern Time. Investors can access the live presentation on the company's corporate website, with a replay available until January 19, 2021. BD is a leading global medical technology company dedicated to enhancing health through innovative technologies and solutions. With 65,000 employees worldwide, BD focuses on advancing clinical therapy, improving diagnostic accuracy, and addressing global health challenges.

FRANKLIN LAKES, N.J., Dec. 22, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the 39^th Annual J.P. Morgan Healthcare Conference via webcast. BD's CEO and president is scheduled to present on Tuesday, January 12, 2021 at 7:30 a.m. Eastern Time.

The live webcast of BD's presentation can be accessed from the BD corporate website at www.bd.com/investors and will be available for replay through Tuesday, January 19, 2021. The accompanying slides will be available at www.bd.com/investors and posted at 6:00 a.m. Eastern Time.

About BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com.

Contact :

Kristen M. Stewart, CFA, Strategy & Investor Relations - 201-847-5378
Kristen Cardillo, Communications - 201-847-5657

View original content:http://www.prnewswire.com/news-releases/bd-to-present-at-the-39th-annual-jp-morgan-healthcare-conference-301197865.html

SOURCE BD (Becton, Dickinson and Company)

FAQ

When will BD present at the 39th Annual J.P. Morgan Healthcare Conference?

BD will present on January 12, 2021, at 7:30 a.m. Eastern Time.

How can I watch the BD presentation at the conference?

The presentation can be watched live on BD's corporate website.

Until when will the BD presentation be available for replay?

The replay of BD's presentation will be available until January 19, 2021.

What is BD's focus in the medical technology sector?

BD focuses on improving medical discovery, diagnostics, and care delivery.

What is BD's commitment to global health?

BD aims to enhance outcomes, lower costs, and improve safety in healthcare.